Advertisement
The presentation is scheduled to begin at 9:30 a.m. Pacific Time onWednesday, Jan. 9, 2008. It will be followed by a separate question-and-answersession at 10 a.m. Pacific Time. Both the presentation and thequestion-and-answer session will be open to all interested parties through alive audiocast accessible via the investor relations section of Hospira's Website at www.hospirainvestor.com. Listeners should log on approximately 10minutes in advance to ensure proper computer setup to receive the audiocast.The slides accompanying the presentation will be available on the Hospira Website at 9:15 a.m. Pacific Time. A replay will be available on the Hospira Website approximately 24 hours after the live presentation until Feb. 1.
Advertisement
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication deliverycompany dedicated to Advancing Wellness(TM) by developing, manufacturing andmarketing products that help improve the productivity, safety and efficacy ofpatient care. In February 2007, Hospira acquired Mayne Pharma Limited tobecome the world leader in specialty generic injectable pharmaceuticals. With70 years of service to the hospital industry, Hospira's portfolio includes oneof the industry's broadest lines of generic acute-care and oncologyinjectables, which help address the high cost of proprietary pharmaceuticals;and integrated solutions for medication management and infusion therapy.Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately15,000 employees worldwide. Hospira's news releases and other information canbe found at www.hospira.com.
SOURCE Hospira, Inc.
